Nothing Special   »   [go: up one dir, main page]
create a website
Pricing in the Market for Anticancer Drugs. (2015). Howard, David H. ; Conti, Rena M. ; Bach, Peter B. ; Berndt, Ernst R..
In: NBER Working Papers.
RePEc:nbr:nberwo:20867.

Full description at Econpapers || Download paper

Cited: 40

Citations received by this document

Cites: 57

References cited by this document

Cocites: 50

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. Competition, value-based prices and incentives to research personalised drugs. (2024). Levaggi, Rosella.
    In: Socio-Economic Planning Sciences.
    RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697.

    Full description at Econpapers || Download paper

  2. Pricing above value: Selling to a market with selection problems. (2024). Boone, Jan.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:94:y:2024:i:c:s0167629624000134.

    Full description at Econpapers || Download paper

  3. Are Medical Care Prices Still Declining? A Re?Examination Based on Cost?Effectiveness Studies. (2022). Dauda, Seidu ; Hall, Anne ; Dunn, Abe.
    In: Econometrica.
    RePEc:wly:emetrp:v:90:y:2022:i:2:p:859-886.

    Full description at Econpapers || Download paper

  4. The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany. (2022). Gandjour, Afschin.
    In: The Quarterly Review of Economics and Finance.
    RePEc:eee:quaeco:v:84:y:2022:i:c:p:502-509.

    Full description at Econpapers || Download paper

  5. A systematic examination of quality-adjusted price index alternatives for medical care using claims data. (2022). Hall, Anne ; Dunn, Abe ; Dauda, Seidu.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:85:y:2022:i:c:s0167629622000819.

    Full description at Econpapers || Download paper

  6. Price Indices and the Value of Innovation with Heterogenous Patients. (2022). Tilipman, Nicholas ; Nicholson, Sean ; Lucarelli, Claudio.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:84:y:2022:i:c:s0167629622000443.

    Full description at Econpapers || Download paper

  7. Novelty and scope of process innovation: The role of related and unrelated manufacturing experience. (2022). Senot, Claire ; Andritsos, Dimitrios A ; Lugovoi, Ivan.
    In: Production and Operations Management.
    RePEc:bla:popmgt:v:31:y:2022:i:10:p:3877-3895.

    Full description at Econpapers || Download paper

  8. Do pharmaceutical prices rise anticipating branded competition?. (2021). Basu, Anirban ; Ellyson, Alice M.
    In: Health Economics.
    RePEc:wly:hlthec:v:30:y:2021:i:5:p:1070-1081.

    Full description at Econpapers || Download paper

  9. A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England. (2021). Hoang, Men Thi ; Wigfield, Peter ; Buyukkaramikli, Nasuh C.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:22:y:2021:i:1:d:10.1007_s10198-020-01228-2.

    Full description at Econpapers || Download paper

  10. The children of the missed pill. (2021). Urzua, Sergio ; Sarzosa, Miguel ; Rau, Tomas.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:79:y:2021:i:c:s0167629621000813.

    Full description at Econpapers || Download paper

  11. Does Medicare Reimbursement Drive Up Drug Launch Prices?. (2020). Ridley, David ; Lee, Chung-Ying.
    In: The Review of Economics and Statistics.
    RePEc:tpr:restat:v:102:y:2020:i:5:p:980-993.

    Full description at Econpapers || Download paper

  12. Pricing above Value: Selling to an Adverse Selection Market. (2020). Boone, Jan.
    In: Other publications TiSEM.
    RePEc:tiu:tiutis:eda6a1de-4db6-49a6-87e4-3fa985b6fe89.

    Full description at Econpapers || Download paper

  13. Pricing above Value: Selling to an Adverse Selection Market. (2020). Boone, Jan.
    In: Other publications TiSEM.
    RePEc:tiu:tiutis:700b2f3e-d1c8-4422-9b54-fe03b51284de.

    Full description at Econpapers || Download paper

  14. Pricing above Value: Selling to an Adverse Selection Market. (2020). boone, jan.
    In: Discussion Paper.
    RePEc:tiu:tiutil:eda6a1de-4db6-49a6-87e4-3fa985b6fe89.

    Full description at Econpapers || Download paper

  15. Pricing above Value: Selling to an Adverse Selection Market. (2020). boone, jan.
    In: Discussion Paper.
    RePEc:tiu:tiucen:700b2f3e-d1c8-4422-9b54-fe03b51284de.

    Full description at Econpapers || Download paper

  16. High prices of new drugs: we are ready to do whatever it takes. (2020). Capri, Stefano.
    In: LIUC Papers in Economics.
    RePEc:liu:liucec:2020-8.

    Full description at Econpapers || Download paper

  17. Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US. (2020). Mossialos, Elias ; Shearer, Emily ; Salas-Vega, Sebastian .
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:258:y:2020:i:c:s0277953620302616.

    Full description at Econpapers || Download paper

  18. Optimal price regulations in international pharmaceutical markets with generic competition. (2020). Saggi, Kamal ; Geng, Difei.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619303844.

    Full description at Econpapers || Download paper

  19. Pricing above value: selling to an adverse selection market. (2020). Boone, Jan.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:15279.

    Full description at Econpapers || Download paper

  20. Health Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion. (2019). Bach, Peter B ; Helms, Zachary ; Ramsey, Scott D ; Basu, Anirban ; Bennette, Caroline Savage.
    In: American Journal of Health Economics.
    RePEc:tpr:amjhec:v:5:y:2019:i:3:p:360-375.

    Full description at Econpapers || Download paper

  21. Does One Medicare Fit All? The Economics of Uniform Health Insurance Benefits. (2019). Skinner, Jonathan ; Baicker, Katherine ; Shepard, Mark.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26472.

    Full description at Econpapers || Download paper

  22. Does One Medicare Fit All? The Economics of Uniform Health Insurance Benefits. (2019). Skinner, Jonathan ; Baicker, Katherine ; Shepard, Mark.
    In: NBER Chapters.
    RePEc:nbr:nberch:14347.

    Full description at Econpapers || Download paper

  23. L’impatto sociale della produzione di scienza su larga scala: come governarlo?. (2019). Giffoni, Francesco ; Florio, Massimo.
    In: Departmental Working Papers.
    RePEc:mil:wpdepa:2019-05.

    Full description at Econpapers || Download paper

  24. The Financial Burden of Cancer: Financial Ratio Analysis. (2019). Kim, Hyungsoo ; Zhang, Qun ; Svynarenko, Radion.
    In: Journal of Family and Economic Issues.
    RePEc:kap:jfamec:v:40:y:2019:i:2:d:10.1007_s10834-018-9587-2.

    Full description at Econpapers || Download paper

  25. Challenges in the value assessment, pricing and funding of targeted combination therapies in oncology. (2019). Garrison, L P ; Blay, J-Y., ; Danko, D.
    In: Health Policy.
    RePEc:eee:hepoli:v:123:y:2019:i:12:p:1230-1236.

    Full description at Econpapers || Download paper

  26. Does One Medicare Fit All? The Economics of Uniform Health Insurance Benefits. (2019). Skinner, Jonathan ; Baicker, Katherine ; Shepard, Mark.
    In: Working Paper Series.
    RePEc:ecl:harjfk:rwp19-036.

    Full description at Econpapers || Download paper

  27. Are Medical Care Prices Still Declining? A Systematic Examination of Quality-Adjusted Price Index Alternatives for Medical Care. (2019). Hall, Anne E ; Dunn, Abe C ; Dauda, Seidu.
    In: BEA Working Papers.
    RePEc:bea:wpaper:0166.

    Full description at Econpapers || Download paper

  28. How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations. (2018). Jaffe, Sonia ; Philipson, Tomas J ; Hult, Kristopher J.
    In: American Journal of Health Economics.
    RePEc:tpr:amjhec:v:4:y:2018:i:4:p:433-453.

    Full description at Econpapers || Download paper

  29. Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?. (2018). PLANCHET, Frédéric ; Eyraud-Loisel, Anne ; Debonneuil, Edouard.
    In: Risks.
    RePEc:gam:jrisks:v:6:y:2018:i:3:p:67-:d:155814.

    Full description at Econpapers || Download paper

  30. Sustainable Reimbursements: Towards a Unified Framework for Pricing Drugs with Significant Uncertainties. (2018). Pani, Luca ; Xoxi, Entela ; Snowberg, Erik ; Mantua, Valentina ; Chassang, Sylvain.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_6846.

    Full description at Econpapers || Download paper

  31. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. (2017). Wirtz, Veronika J ; Ferrario, Alessandra ; Paris, Valerie ; Vogler, Sabine ; Dedet, Guillaume ; Pedersen, Hanne Bak ; Schneider, Peter ; Joncheere, Kees .
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0300-z.

    Full description at Econpapers || Download paper

  32. How can pricing and reimbursement policies improve affordable access to medicines? Lessons learned from European countries. (2017). Babar, Zaheer-Ud-Din, ; Dedet, Guillaume ; Pedersen, Hanne Bak ; Schneider, Peter ; de Joncheere, Kees ; Wirtz, Veronika J ; Ferrario, Alessandra ; Paris, Valerie ; Vogler, Sabine.
    In: LSE Research Online Documents on Economics.
    RePEc:ehl:lserod:68862.

    Full description at Econpapers || Download paper

  33. The Effects of Pharmaceutical Innovation on Cancer Mortality Rates. (2016). Dubois, Pierre ; Kyle, Margaret .
    In: TSE Working Papers.
    RePEc:tse:wpaper:30703.

    Full description at Econpapers || Download paper

  34. How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations. (2016). Philipson, Tomas ; Jaffe, Sonia ; Hult, Kristopher.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:22986.

    Full description at Econpapers || Download paper

  35. Insurance and the High Prices of Pharmaceuticals. (2016). Dranove, David ; Besanko, David ; Garthwaite, Craig.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:22353.

    Full description at Econpapers || Download paper

  36. The Effects of Pharmaceutical Innovation on Cancer Mortality. (2016). Dubois, Pierre ; Kyle, Margaret K.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:11487.

    Full description at Econpapers || Download paper

  37. Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection. (2016). Seabury, Seth ; Lakdawalla, Darius ; Goldman, Dana ; Seth, Seabury ; Charu, Gupta ; Darius, Lakdawalla ; Dana, Goldman ; Zeba, Khan ; Tomas, Philipson ; Amitabh, Chandra .
    In: Forum for Health Economics & Policy.
    RePEc:bpj:fhecpo:v:19:y:2016:i:1:p:141-156:n:6.

    Full description at Econpapers || Download paper

  38. Adjusting the Measurement of the Output of the Medical Sector for Quality: A Review of the Literature. (2015). Hall, Anne E..
    In: BEA Working Papers.
    RePEc:bea:wpaper:0122.

    Full description at Econpapers || Download paper

References

References cited by this document

  1. Akscin, John, Thomas R. Barr, and Elaine L. Towle. 2007. “Key Practice Indicators in OfficeBased Oncology Practices: 2007 Report on 2006 Data.” Journal of Clinical Oncology 3(4): 2003.
    Paper not yet in RePEc: Add citation now
  2. Anand, Geeta. 2007. “Prescribing Caution: From Wall Street, a Warning About Cancer-Drug Prices; Morgan Stanley Analyst Creates Stir in Industry As He Sees a Backlash.” Wall Street Journal, March 15. http://online.wsj.com/news/articles/SB117391934158537592 Bach, Peter B. 2009. “Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs.” New England Journal of Medicine 360(6): 626-33.
    Paper not yet in RePEc: Add citation now
  3. Bach, Peter B., Leonard B. Saltz, and Robert E. Wittes. 2012. “In Cancer Care, Cost Matters.” The New York Times, October 14. http://www.nytimes.com/2012/10/15/ Conti, Rena M., Peter B. Bach. 2013. “Cost Consequences of the 340B Drug Discount Program.” Journal of the American Medical Association 309(19): 1995-6.
    Paper not yet in RePEc: Add citation now

  4. Berndt, Ernst R., David Cutler, Richard G. Frank, Zvi Griliches, Joseph P. Newhouse, and Jack E. Triplett, 2000. “Medical Care Prices and Output,” Chap. 3, In Handbook of Health Economics, Vol. 1A. edited by J.P. Newhouse and A.C. Culyer. Amsterdam: Elsevier Science B.V. Berndt, Ernst R., and Joseph P. Newhouse. 2012. “Pricing and Reimbursement in US Pharmaceutical Markets.” Chap. 8 in The Oxford Handbook of the Economics of the Biopharmaceutical Industry, edited by P.M. Danzon and S.N. Nicholson. New York, NY: Oxford University Press.

  5. Biotechnology Industry Organization. 2013. The 340B Drug Discount Program.
    Paper not yet in RePEc: Add citation now

  6. Busch, Susan H., Ernst R. Berndt, and Richard G. Frank. 2001. “Creating Price Indexes for Measuring Productivity in Mental Health Care.” Chap. 5 in Frontiers in Health Policy Research, Vol. 4, edited by A.M. Garber. Cambridge, MA: MIT Press for the National Bureau of Economic Research.

  7. Cavalli, Franco. 2013. “An Appeal to World Leaders: Stop Cancer Now.” The Lancet 381(9865): 425-6.
    Paper not yet in RePEc: Add citation now
  8. Caves, Richard E., Michael D. Whinston, and Mark A. Hurwitz. 1991. “Patent Expiration, Entry and Competition in the US Pharmaceutical Industry: An Exploratory Analysis.” Brookings Papers on Economic Activity. Microeconomics 1-48.
    Paper not yet in RePEc: Add citation now
  9. Center for Medicare & Medicaid Services. 2014. CMS proposes program changes for Medicare Advantage and Prescription Drug Benefit Programs for Contract Year 2015 (CMS-4159-P).
    Paper not yet in RePEc: Add citation now
  10. Cockburn, Iain M., and Aslam H. Anis. 2001. “Hedonic Analysis of Arthritis Drugs.” Chap. 11 in Medical Care Output and Productivity, edited by E. Berndt and D. Cutler. Chicago, IL: University of Chicago Press.
    Paper not yet in RePEc: Add citation now
  11. Conti, Rena M., and Peter B. Bach. 2013. “Cost Consequences of the 340B Drug Discount Program.” Journal of the American Medical Association 309(19): 1995-6.
    Paper not yet in RePEc: Add citation now
  12. Conti, Rena M., Arielle C. Bernstein, Victoria M. Villaflor, Richard L. Schilsky, Meredith B. Rosenthal, and Peter B. Bach. 2013. “Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists.” Journal of Clinical Oncology 31(9): 1134-9.
    Paper not yet in RePEc: Add citation now
  13. Cutler. 2007. “The Value of Medical Interventions for Lung Cancer in the Elderly: Results from SEER-CMHSF.” Cancer 110(11): 2511-8. Price on log scale ($1,000s of USD) 0.1 0.2 0.5 1.0 2.0 3.0 5.0 Life years gained on log scale (years) Source of survival benefit: Trial, overall survival Trial, progression-free survival Modelling study Source: Authors
    Paper not yet in RePEc: Add citation now
  14. Dendreon. 2014. Patient Access. http://www.dendreon.com/patient_resources/patient_access/ Drug Discount Monitor. 2014. 340B Sales Totaled $7.5 Billion in 2013, Apexus Says. February 14. http://drugdiscountmonitor.com/2014/02/340b-sales-totaled-7-5-billion-in-2013-apexus-says/ Experts in Chronic Myeloid Leukemia. 2013. “The Price of Drugs for Chronic Myeloid Leukemia (CML) is a Reflection of the Unsustainable Prices of Cancer Drugs: From the Perspective of a Large Group of CML Experts.” Blood 121(22): 4439-42.
    Paper not yet in RePEc: Add citation now
  15. Fleck, Leonard. 2013. Just Caring: Can We Afford the Ethical and Economic Costs of Circumventing Cancer Drug Resistance?” Journal of Personalized Medicine 3(3): 124-43.
    Paper not yet in RePEc: Add citation now

  16. Frank, Richard G., and David S. Salkever. 1997. “Generic Entry and the Pricing of Pharmaceuticals.” Journal of Economics and Management Strategy 6(1): 75-90.

  17. Frey, Bruno S., and Werner W. Pommerehne. 1993. “On the Fairness of Pricing--An Empirical Survey among the General Population.” Journal of Economic Behavior and Organization 20(3): 295-307.

  18. Gingrich, Newt. 2009. “Trust the Government.” Human Events. August 12. http://humanevents.com/2009/08/12/trust-the-government/ Goldman, Dana P., Anupam B. Jena, Darius N. Lakdawalla, Jennifer L. Malin, Jesse D. Malkin, and Eric Sun. 2010. “The Value of Specialty Oncology Drugs.” Health Service Research 45(1): 115-32.
    Paper not yet in RePEc: Add citation now
  19. Griffith, Victoria. 2004. “Pricing Weighs on Cancer Treatments.” Financial Times, June 03.
    Paper not yet in RePEc: Add citation now
  20. Howard, David H. 2014. “Drug Companies’ Patient-Assistance Programs – Helping Patients or Profits?” New England Journal of Medicine. 371(2): 97-9.
    Paper not yet in RePEc: Add citation now
  21. http://online.wsj.com/news/articles/SB10001424127887324522504579000560184822956 Kantarjian, Hagop M, Tito Fojo, Michael Mathisen, and Leonard A. Zwelling. 2013. “Cancer Drugs in the United States: Justum Pretium--The Just Price.” Journal of Clinical Oncology 31(28): 3600-4.
    Paper not yet in RePEc: Add citation now

  22. http://www.bio.org/sites/default/files/340B percent20White percent20Paper percent20FINAL.pdf Budish, Eric, Benjamin N. Roin, Heidi Williams. 2013. “Do Fixed Patent Terms Distort Innovation? Evidence from Cancer Clinical Trials.” National Bureau of Economic Research working paper 19430.

  23. http://www.fda.gov/ForPatients/Approvals/Fast/default.htm US General Accounting Office. 2011. Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement. Washington, D.C.
    Paper not yet in RePEc: Add citation now
  24. http://www.ft.com/intl/cms/s/0/8a7697f6-b4fa-11d8-81c6-000e2511c801.html#axzz38sOrHssv Hall, Stephen S. 2013. “The Cost of Living.” New York Magazine. October 20. http://nymag.com/news/features/cancer-drugs-2013-10/ Hirth, Richard A, Michael E. Chernew, Edward Miller, A. Mark Fendrick and William G.
    Paper not yet in RePEc: Add citation now
  25. Hutchison, Courtney. 2010. “Provenge Cancer Vaccine: Can You Put a Price on Delaying Death?” ABC News. July 29. http://abcnews.go.com/Health/ProstateCancerNews/provengecancer -vaccine-months-life-worth-100k/story?id=11269159 IMS Institute for Healthcare Informatics. 2014. “Innovation in Cancer Care and Implications for Health Systems: Global Oncology Trend Report” Available at: http://www.imshealth.com/portal/site/imshealth/menuitem.762a961826aad98f53c753c71ad8c22 a/?vgnextoid=f8d4df7a5e8b5410VgnVCM10000076192ca2RCRD.
    Paper not yet in RePEc: Add citation now
  26. InsideHealthPolicy. 2014. MedPAC Explores Fixes To Part B Drug Payment Policy, Calls Current System ‘Perverse Incentive’. http://www.pipcpatients.org/pipcadmin /pdf/cde114_MedPAC%20Explores%20Fixes%20To%20Part%20B%20Drug%20Paymen t%20Policy.pdf Jacobson, Mireille, A. James O’Malley, Craig C. Earle, Juliana Pakes, Peter Gaccione, and Joseph P.Newhouse. 2006. “Does Reimbursement Influence Chemotherapy Treatment for Cancer Patients?” Health Affairs 25(2): 437-43.
    Paper not yet in RePEc: Add citation now
  27. Jacobson, Mireille, Craig C. Earle, Mary Price, and Joseph P. Newhouse. 2010. “How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment.” Health Affairs 29(7): 1391-9.
    Paper not yet in RePEc: Add citation now

  28. January 6. http://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-Sheets/2014-Factsheets -items/2014-01-06.html CenterWatch. 2014. FDA Approved Drugs for Oncology. http://www.centerwatch.com/druginformation /fda-approved-drugs/therapeutic-area/12/ Chen, Jie, and John A. Rizzo. 2012. “Pricing Dynamics and Product Quality: The Case of Antidepressant Drugs.” Empirical Economics 42(1): 279-300.

  29. Kahneman, Daniel, Jack L. Knetsch, and Richard H. Thaler, 1986. “Fairness as a Constraint on Profit Seeking: Entitlements in the Market.” American Economic Review 76(4): 728-41.

  30. Kaiser Family Foundation and Health Research & Educational Trust. 2013. Employer Health Benefits. 2013 Annual Survey. Washington, D.C.: Kaiser Family Foundation and Health Research & Educational Trust.
    Paper not yet in RePEc: Add citation now

  31. Kalyanaram, Gurumurthy, and John D.C. Little. 1994. “An Empirical Analysis of Latitude of Price Acceptance in Consumer Package Goods.” Journal of Consumer Research 21(3): 408-18.

  32. Lakdawalla, Darius N, John A. Romley, Yuri Sanchez, J. Ross Maclean, John R. Penrod, and Tomas Philipson. 2012. “How Cancer Patients Value Hope and the Implications for CostEffectiveness Assessments of High-Cost Cancer Therapies.” Health Affairs 31(4): 676-82.
    Paper not yet in RePEc: Add citation now
  33. Landsem, Hope. 2013. “Rationing Health Care in Oregon.” Wall Street Journal, August 8.
    Paper not yet in RePEc: Add citation now
  34. Lichtenberg, Frank R. 2009. “International Differences in Cancer Survival Rates: The Role of New Drug Launches.” International Journal of Healthcare Technology and Management 10(3): 138-55.
    Paper not yet in RePEc: Add citation now

  35. Lichtenberg, Frank. 2009. “The Effect of New Cancer Drug Approvals on the Life Expectancy of American Cancer Patients, 1978-2004.” Economics of Innovation and New Technology 18(5): 407-28.

  36. Lu, Z. John and William S. Comanor. 1998. “Strategic Pricing of New Pharmaceuticals. Review of Economics and Statistics 80(1): 108-18.

  37. Lucarelli, Claudio, and Sean Nicholson, 2009, “A Quality-Adjusted Price Index for Colorectal Cancer Drugs.” National Bureau of Economic Research working paper 15174.

  38. Marcus, Amy D. 2004. “Price Becomes Factor in Cancer Treatment.” Wall Street Journal September 7. http://online.wsj.com/news/articles/SB109450779986210547 Mas, Alexandre. 2006. “Pay, Reference Points, and Police Performance.” Quarterly Journal of Economics 121(3): 783-821.
    Paper not yet in RePEc: Add citation now

  39. Maxwell, Sarah. 2002. “Rule-Based Price Fairness and Its Effect on Willingness to Purchase.” Journal of Economic Psychology 23(2): 191-212.

  40. National Cancer Institute. 2014. Cancer Drug Information. http://www.cancer.gov/cancertopics/druginfo/alphalist Neumann, Peter J. 2005. Using Cost-Effectiveness Analysis to Improve Health Care. Oxford, United Kingdom; Oxford University Press.
    Paper not yet in RePEc: Add citation now
  41. National Comprehensive Cancer Network. 2010. Guidelines for Breast Cancer Updated; Bevacizumab Recommendation Affirmed. http://www.nccn.org/about/news/newsinfo.asp?NewsID = 259.
    Paper not yet in RePEc: Add citation now

  42. Newhouse, Joseph P. 1992. Medical Care Costs: How Much Welfare Loss? Journal of Economic Perspectives 6(3): 3-21.

  43. Niraula, Saroj, Bostjan Seruga, Alberto Ocana, Tiffany Shao Robyn Goldstein, Ian F. Tannock, and Eitan Amir. 2012. “The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs.” Journal of Clinical Oncology 30(24): 3012-9.
    Paper not yet in RePEc: Add citation now
  44. PhRMA (Pharmaceutical Research and Manufacturers of America). 2014. Medicines in Development. 2014. http://www.phrma.org/innovation/meds-in-development Piron, Robert, and Luis Fernandez. 1995. “Are Fairness Constraints on Profit-Seeking Important?” Journal of Economic Psychology 16(1): 73-96.
    Paper not yet in RePEc: Add citation now
  45. Raborn Martin L., Elise M. Pelletier, Daniel B. Smith, and Carolina M. Reyes. 2012. “Patient Out-of-Pocket Payments for Oral Oncolytics: Results from a 2009 US Claims Data Analysis.” American Journal of Managed Care 18(5 No. 2): SP57-64.
    Paper not yet in RePEc: Add citation now

  46. Reekie, W. Duncan. 1978. “Price and Quality Competition in the United States Drug Industry.” The Journal of Industrial Economics 26(3): 223-37.

  47. Romley, John A, Yuri Sanchez, John R. Penrod, and Dana P. Goldman. 2012. “Survey Results Show That Adults are Willing to Pay Higher Insurance Premiums for Generous Coverage of Specialty Drugs.” Health Affairs 31(4): 683-90.
    Paper not yet in RePEc: Add citation now
  48. Schrag, Deborah. 2004. “The Price Tag on Progress--Chemotherapy for Colorectal Cancer.” New England Journal of Medicine 351(4): 317-9.
    Paper not yet in RePEc: Add citation now
  49. Seabury, Seth A., Dana P. Goldman, J. Ross Maclean, John R. Penrod, and Darius N. Lakdawalla. 2012. “Patients Value Metastatic Cancer Therapy More Highly Than is Typically Shown Through Traditional Estimates.” Health Affairs 31(4): 691-9.
    Paper not yet in RePEc: Add citation now
  50. Silber, Judy. 2005. Onyx Gets OK for Kidney Cancer Drug. Contra Costa Times December 21.
    Paper not yet in RePEc: Add citation now

  51. Sun, Eric, Anupam B. Jena, Darius Lakdawalla, Carolina Reyes, Tomas J. Philipson, and Dana Goldman. 2010. “The Contributions of Improved Therapy and Early Detection to Cancer Survival Gains, 1988-2000.” Forum for Health Economics & Policy 13(2): 1-20.

  52. Suslow, Valerie Y. 1996. “Measuring Quality Change in Pharmaceutical Markets: Hedonic Price Indexes for Anti-Ulcer Drugs.” Chap. 4 in Competitive Strategies in the Pharmaceutical Industry, edited by R. Helms. Washington, D.C.: American Enterprise Institute.
    Paper not yet in RePEc: Add citation now
  53. Szabo, Liz. 2004 “Price of Cancer Drugs Called ‘Mind-Boggling’” USA Today. July 21. http://usatoday30.usatoday.com/news/health/2004-07-21-cancer-usat_x.htm Thaler Richard. 1985, “Mental Accounting and Consumer Choice,” Marketing Science 4(3): 199-214.
    Paper not yet in RePEc: Add citation now
  54. Trusheim, Mark R., and Ernst R. Berndt. 2012. “The Segmentation of Therapeutic Populations in Oncology.” Health Management, Policy and Innovation 1(1): 19-34.
    Paper not yet in RePEc: Add citation now
  55. US Food and Drug Administration. 2014a. Table of Pharmacogenomic Biomarkers in Drug Labeling. August 18. http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm US Food and Drug Administration. 2014. Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review. September 18, 2014.
    Paper not yet in RePEc: Add citation now
  56. Weissert. 2000. “Willingness to Pay for a Quality-Adjusted Life Year: In Search of a Standard.” Medical Decision Making 20(3): 332-42.
    Paper not yet in RePEc: Add citation now
  57. Wittes, Robert E. 2004. “Cancer Weapons, Out of Reach.” Washington Post June 15. http://www.washingtonpost.com/wp-dyn/articles/A42035-2004Jun14.html Woodward, Rebecca M, Martin L. Brown, Susan T. Stewart, Kathleen A. Cronin, and David M.
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Factors related to excessive out-of-pocket expenditures among the ultra-poor after discontinuity of PBF: a cross-sectional study in Burkina Faso. (2020). Souleymane, Sidibe ; Bonnet, Emmanuel ; Ridde, Valery ; Beauge, Yvonne ; Allegri, Manuela ; Kuunibe, Naasegnibe.
    In: Health Economics Review.
    RePEc:spr:hecrev:v:10:y:2020:i:1:d:10.1186_s13561-020-00293-w.

    Full description at Econpapers || Download paper

  2. Education and mental health: Evidence and mechanisms. (2020). Lu, Yi ; Xie, Huihua ; Jiang, Wei.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:180:y:2020:i:c:p:407-437.

    Full description at Econpapers || Download paper

  3. Controlling Sellers Who Provide Advice: Regulation and Competition. (2020). MARTIMORT, David ; Bardey, David ; Gromb, Denis ; Pouyet, Jerome.
    In: Journal of Industrial Economics.
    RePEc:bla:jindec:v:68:y:2020:i:3:p:409-444.

    Full description at Econpapers || Download paper

  4. Rural Exodus and Standard of Living. (2019). Sturm, Jan-Egbert ; Hartwig, Jochen.
    In: Chemnitz Economic Papers.
    RePEc:tch:wpaper:cep001.

    Full description at Econpapers || Download paper

  5. Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems. (2019). Eggleston, Karen ; Iizuka, Toshiaki ; Feenstra, Talitha ; Chen, Ying Isabel ; Newhouse, Joseph P ; Quan, Jianchao ; Struijs, Jeroen N ; Rodriguez-Sanchez, Beatriz ; Lu, Jui-Fen Rachel ; Leung, Gabriel M ; Lam, Janet Tinkei.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25971.

    Full description at Econpapers || Download paper

  6. Physician agency in China: Evidence from a drug-percentage incentive scheme. (2019). Wu, Bingxiao.
    In: Journal of Development Economics.
    RePEc:eee:deveco:v:140:y:2019:i:c:p:72-89.

    Full description at Econpapers || Download paper

  7. Testing the Grossman model of medical spending determinants with macroeconomic panel data. (2018). Sturm, Jan-Egbert ; Hartwig, Jochen.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:19:y:2018:i:8:d:10.1007_s10198-018-0958-2.

    Full description at Econpapers || Download paper

  8. An Analytical Model of Demand for Hospital Inpatient Care. (2018). Eze, Pius.
    In: International Journal of Social Sciences Perspectives.
    RePEc:oap:ijossp:2018:p:80-86.

    Full description at Econpapers || Download paper

  9. Equitable decision making approaches over allocations of multiple benefits to multiple entities. (2018). Kaynar, Nur ; Karsu, Ozlem.
    In: Omega.
    RePEc:eee:jomega:v:81:y:2018:i:c:p:85-98.

    Full description at Econpapers || Download paper

  10. Toward a new conceptualization of health care services to inspire public health. Public national health service as a “common pool of resources”. (2017). Palumbo, Rocco.
    In: International Review on Public and Nonprofit Marketing.
    RePEc:spr:irpnmk:v:14:y:2017:i:3:d:10.1007_s12208-017-0175-1.

    Full description at Econpapers || Download paper

  11. Identification determinant factors on willingness to pay for health services in Iran. (2017). Khammarnia, Mohammad ; Faramarzi, Ahmad ; Kavosi, Zahra ; Javan-Noughabi, Javad.
    In: Health Economics Review.
    RePEc:spr:hecrev:v:7:y:2017:i:1:d:10.1186_s13561-017-0179-x.

    Full description at Econpapers || Download paper

  12. Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget survey. (2017). Theurl, Engelbert ; Sanwald, Alice .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:18:y:2017:i:4:d:10.1007_s10198-016-0797-y.

    Full description at Econpapers || Download paper

  13. The Trade and Health Effects of Tobacco Regulations. (2017). Galinato, Gregmar ; Yoder, Jonathan K ; Olanie, Aaron Z.
    In: Journal of Agricultural and Resource Economics.
    RePEc:ags:jlaare:264066.

    Full description at Econpapers || Download paper

  14. Implications of Increasing Cigarette Taxes in Peru. (2016). Gonzalez-Rozada, Martin ; Ramos-Carbajales, Alejandro.
    In: Department of Economics Working Papers.
    RePEc:udt:wpecon:2016_02.

    Full description at Econpapers || Download paper

  15. The Icelandic economic collapse, smoking, and the role of labor-market changes. (2015). Olafsdottir, Thorhildur ; Hrafnkelsson, Birgir ; asgeirsdottir, Tinna .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:16:y:2015:i:4:p:391-405.

    Full description at Econpapers || Download paper

  16. Price elasticities of alcohol demand: evidence from Russia. (2015). Goryakin, Yevgeniy ; McKee, Martin ; Roberts, Bayard.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:16:y:2015:i:2:p:185-199.

    Full description at Econpapers || Download paper

  17. Pricing in the Market for Anticancer Drugs. (2015). Howard, David H. ; Conti, Rena M. ; Bach, Peter B. ; Berndt, Ernst R..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:20867.

    Full description at Econpapers || Download paper

  18. Under regional characteristics of rural China: a clearer view on the performance of the New Rural Cooperative Medical Scheme. (2015). von Braun, Joachim ; Litaker, David ; Tsegai, Daniel ; Liu, Dan.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:15:y:2015:i:4:p:407-431.

    Full description at Econpapers || Download paper

  19. Technological Adoption in Health Care – The Role of Payment Systems. (2015). Martinez-Giralt, Xavier ; Barros, Pedro ; Pita, Barros Pedro ; Xavier, Martinez-Giralt .
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:15:y:2015:i:2:p:709-745:n:16.

    Full description at Econpapers || Download paper

  20. Medical Care Expenditure Indexes for the US, 1980-2006. (2015). HIGHFILL, TINA ; Aizcorbe, Ana .
    In: BEA Working Papers.
    RePEc:bea:wpaper:0121.

    Full description at Econpapers || Download paper

  21. Lead me not into temptation: drug price regulation and dispensing physicians in Switzerland. (2014). Rischatsch, Maurus .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:15:y:2014:i:7:p:697-708.

    Full description at Econpapers || Download paper

  22. Explaining differences in remuneration rates of nursing homes in Germany. (2014). Wasem, Juergen ; Mennicken, Roman ; Augurzky, Boris ; Rothgang, Heinz.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:15:y:2014:i:4:p:401-410.

    Full description at Econpapers || Download paper

  23. The Regional Economic Impacts of Austrian Hospitals. (2013). Fritz, Oliver ; Ostermann, Herwig ; Bachner, Florian ; Streicher, Gerhard ; Haller, Reinhard ; Mayerhofer, Peter.
    In: WIFO Studies.
    RePEc:wfo:wstudy:46672.

    Full description at Econpapers || Download paper

  24. Effects of Subsidized Health Insurance on Newborn Health in a Developing Country. (2013). Conover, Emily ; Camacho, Adriana.
    In: Economic Development and Cultural Change.
    RePEc:ucp:ecdecc:doi:10.1086/669263.

    Full description at Econpapers || Download paper

  25. The effect of stimulants and their combined use with cigarettes on mortality: the case of betel quid. (2013). Keng, Shao-Hsun ; Sheu, Sheng-Jang .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:4:p:677-695.

    Full description at Econpapers || Download paper

  26. What do physicians dislike about managed care? Evidence from a choice experiment. (2013). Zweifel, Peter ; Rischatsch, Maurus .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:4:p:601-613.

    Full description at Econpapers || Download paper

  27. Incentive-Compatible Reimbursement Schemes for Physicians. (2013). Emons, Winand.
    In: Journal of Institutional and Theoretical Economics (JITE).
    RePEc:mhr:jinste:urn:sici:0932-4569(201312)169:4_605:irsfp_2.0.tx_2-9.

    Full description at Econpapers || Download paper

  28. Duopoly Competition and Regulation in a Two-Sided Health Care Insurance Market with Product Differentiation. (2013). Boilley, Audrey .
    In: Working Papers.
    RePEc:crb:wpaper:2013-02.

    Full description at Econpapers || Download paper

  29. Willingness‐to‐pay for parallel private health insurance: evidence from a laboratory experiment. (2012). Nuscheler, Robert ; McLeod, Logan ; Cuff, Katherine ; Buckley, Neil ; Cameron, David ; Hurley, Jeremiah.
    In: Canadian Journal of Economics/Revue canadienne d'économique.
    RePEc:wly:canjec:v:45:y:2012:i:1:p:137-166.

    Full description at Econpapers || Download paper

  30. Medical guidelines, physician density, and quality of care: evidence from German SHARE data. (2012). Pohl, R. Vincent ; Juerges, Hendrik ; Jurges, Hendrik.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:13:y:2012:i:5:p:635-649.

    Full description at Econpapers || Download paper

  31. Fiscal federalism and income redistribution through healthcare financing: An empirical analysis for the Swiss cantons. (2012). Crivelli, Luca ; Salari, Paola .
    In: CEPRA working paper.
    RePEc:lug:wcepra:1204.

    Full description at Econpapers || Download paper

  32. Does Health Insurance Make You Fat?. (2011). Bhattacharya, Jay ; Pace, Noemi ; Sood, Neeraj ; Bundorf, Kate M..
    In: NBER Chapters.
    RePEc:nbr:nberch:11825.

    Full description at Econpapers || Download paper

  33. Dynamic linear economies with social interactions. (2011). Ozgur, Onur ; Bisin, Alberto.
    In: Levine's Working Paper Archive.
    RePEc:cla:levarc:786969000000000036.

    Full description at Econpapers || Download paper

  34. Primary care delivery, risk pooling and economic efficiency. (2010). Leung, Michael.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:11:y:2010:i:2:p:161-175.

    Full description at Econpapers || Download paper

  35. Cardinal Scales for Health Evaluation. (2010). Østerdal, Lars Peter ; Osterdal, Lars Peter ; Harvey, Charles M.
    In: Decision Analysis.
    RePEc:inm:ordeca:v:7:y:2010:i:3:p:256-281.

    Full description at Econpapers || Download paper

  36. Targeting in Social Programs: Avoiding Bad Bets, Removing Bad Apples. (2009). Sari, Nazmi.
    In: Review of Social Economy.
    RePEc:taf:rsocec:v:67:y:2009:i:1:p:117-119.

    Full description at Econpapers || Download paper

  37. Optimal accident compensation schemes. (2009). Watt, Richard ; Vazquez, Francisco.
    In: Spanish Economic Review.
    RePEc:spr:specre:v:11:y:2009:i:1:p:75-82.

    Full description at Econpapers || Download paper

  38. Vazby vzdělání a zdraví v kontextu ekonomického rozvoje. (2009). Mertl, Jan ; Vychova, Helena .
    In: Politická ekonomie.
    RePEc:prg:jnlpol:v:2009:y:2009:i:1:id:670:p:58-78.

    Full description at Econpapers || Download paper

  39. Does Health Insurance Make You Fat?. (2009). Sood, Neeraj ; Pace, Noemi ; Bhattacharya, Jay ; Bundorf, Kate .
    In: NBER Working Papers.
    RePEc:nbr:nberwo:15163.

    Full description at Econpapers || Download paper

  40. The effect of physicians’ remuneration system on the Caesarean section rate: the Uruguayan case. (2009). Triunfo, Patricia ; Rossi, Maximo.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:9:y:2009:i:4:p:333-345.

    Full description at Econpapers || Download paper

  41. Economic incentives in general practice: The impact of pay-for-participation and pay-for-compliance programs on diabetes care. (2009). UGOLINI, CRISTINA ; Lippi Bruni, Matteo ; Nobilio, Lucia .
    In: Health Policy.
    RePEc:eee:hepoli:v:90:y:2009:i:2-3:p:140-148.

    Full description at Econpapers || Download paper

  42. Technological adoption in health care. (2009). Martinez-Giralt, Xavier ; Barros, Pedro ; Barros, Pedro Luis Pita, .
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:7558.

    Full description at Econpapers || Download paper

  43. Technological adoption in health care. (2009). Martinez-Giralt, Xavier ; Barros, Pedro.
    In: Working Papers.
    RePEc:bge:wpaper:413.

    Full description at Econpapers || Download paper

  44. Algorithmic Prediction of Health-Care Costs. (2008). Bertsimas, Dimitris ; Wang, Grant ; Vempala, Santosh ; Pandey, Rudra ; Kryder, Christian J ; Kane, Michael A ; Bjarnadottir, Margret V.
    In: Operations Research.
    RePEc:inm:oropre:v:56:y:2008:i:6:p:1382-1392.

    Full description at Econpapers || Download paper

  45. Effects of Subsidized Health Insurance on Newborn Health in Colombia. (2008). Conover, Emily ; Camacho, Adriana.
    In: DOCUMENTOS CEDE.
    RePEc:col:000089:005007.

    Full description at Econpapers || Download paper

  46. The Importance of Objective Health Measures in Predicting Early Receipt of Social Security Benefits: The Case of Fatness. (2006). Cawley, John ; Burkhauser, Richard.
    In: Working Papers.
    RePEc:mrr:papers:wp148.

    Full description at Econpapers || Download paper

  47. Efficiency of Thai Provincial Public Hospitals after the Introduction of National Health Insurance Program. (2006). Rosenman, Robert ; Puenpatom, Amy R.
    In: Working Papers.
    RePEc:ags:wsuewp:12960.

    Full description at Econpapers || Download paper

  48. The Sisyphus Syndrome in Health Revisited. (2005). Zweifel, Peter ; Eugster, Patrick ; Steinmann, Lukas .
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:5:y:2005:i:2:p:127-145.

    Full description at Econpapers || Download paper

  49. Patient Choice in Kidney Allocation: The Role of the Queueing Discipline. (2004). Zenios, Stefanos ; Su, Xuanming .
    In: Manufacturing & Service Operations Management.
    RePEc:inm:ormsom:v:6:y:2004:i:4:p:280-301.

    Full description at Econpapers || Download paper

  50. Anchor Levels as a New Tool for the Theory and Measurement of Multiattribute Utility. (2004). Wakker, Peter ; Stiggelbout, Anne M.
    In: Decision Analysis.
    RePEc:inm:ordeca:v:1:y:2004:i:4:p:217-234.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2024-11-29 11:25:00 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.